NEW
YORK, July 30, 2024 /PRNewswire/ -- The global
cell culture market size is estimated to grow by USD 24.8 billion from 2024-2028, according
to Technavio. The market is estimated to grow at a CAGR of
almost 13.64% during the forecast period. Increase in
infectious diseases is driving market growth, with a trend towards
increasing demand for 3d cell culture. However, contamination of
cell culture poses a challenge. Key market players include Agilent
Technologies Inc., Avantor Inc., Becton
Dickinson and Co., Bio Techne Corp., CLS Cell Lines Service
GmbH, Corning Inc., Danaher Corp., Eppendorf SE, FUJIFILM Holdings
Corp., General Electric Co., InvivoGen Corp., LABGENE Scientific
SA, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. And Co. KG,
PromoCell GmbH, Sartorius AG, Sartorius CellGenix GmbH, Thermo
Fisher Scientific Inc., and ZenBio Inc..
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Product (Consumables
and Equipment), End-user (Pharma and biotech companies, Hospitals,
Research and academic Institutes, and Others), and Geography (North
America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Agilent Technologies
Inc., Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., CLS
Cell Lines Service GmbH, Corning Inc., Danaher Corp., Eppendorf SE,
FUJIFILM Holdings Corp., General Electric Co., InvivoGen Corp.,
LABGENE Scientific SA, Lonza Group Ltd., Merck KGaA, Miltenyi
Biotec B.V. And Co. KG, PromoCell GmbH, Sartorius AG, Sartorius
CellGenix GmbH, Thermo Fisher Scientific Inc., and ZenBio
Inc.
|
Key Market Trends Fueling Growth
The 3D cell culture market is experiencing significant growth
due to the increasing adoption of this technology in various
research fields. In 3D cell culture, biological cells are grown in
an artifically created environment, mimicking normal cell
morphology. This technique is valuable for studying stem cells,
viral pathogenesis, and cancer research. Companies like Thermo
Fisher Scientific and Merck KGaA provide 3D cell culture products,
such as Thermo Fisher Scientific's AlgiMatrix 3D Culture System and
Merck KGaA's 3D Collagen Culture Kit. These products closely
simulate the natural cellular environment, enabling detailed
analysis of cell growth, drug resistance, apoptosis, angiogenesis,
and tissue formation. Furthermore, the potential for personalized
treatment plans using patient cells is driving innovation in 3D
cell culture models. As a result, the demand for advanced 3D cell
culture techniques is increasing, leading to market expansion
during the forecast period.
The Cell Culture Market is experiencing significant growth due
to increasing trends in areas like buying behavior for single-use
technologies, novel therapeutics for chronic diseases, and research
in cell biology, particularly in cancer and cardiovascular
ailments. The Biotechnology industry's focus on cell therapy, as
seen in companies like CellVovant and collaborations between
universities like the University of Bristol and biotech firms, is driving
innovation. Seed funding and regulatory requirements are shaping
the landscape for biopharmaceutical sectors in healthcare markets.
Microcarrier-based technologies and emerging countries are reducing
cost and process development time, attracting investments in
biopharmaceutical production. However, concerns around plastic
waste from single-use bioprocessing and solid waste from
diagnostics and tissue engineering need addressing. The market
encompasses drug research activities, vaccine production,
therapeutic proteins, monoclonal antibodies, and diagnostics.
Biotech companies and diagnostic laboratories are key players, with
a focus on viral vaccines, biopharmaceutical development, and
pharmaceuticals.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Cell culture is a process used to cultivate cells from plants
or animals in an artificial environment. Contamination is a
significant challenge in cell culture, which can lead to high
losses and decreased productivity. Chemical contamination can arise
from adulterated media, impure water, endotoxins, free radicals,
plasticizers, detergents, and disinfectants. Biological
contamination can be caused by bacteria, yeast, molds, viruses,
mycoplasmas, protozoa, invertebrates, and cross-contamination from
other cell lines. Molds, yeast, and bacteria are common
contaminants due to their ubiquitous presence. Virus contamination
is difficult to detect and remove from media. Contamination leads
to significant losses and decreases overall production and market
revenue. To minimize contamination, lab professionals must check
the consistency of the medium and follow strict aseptic techniques.
Failure to do so can result in the loss of valuable sources and
time, ultimately impacting market growth negatively. Therefore, the
presence of contamination factors may hinder the growth of the cell
culture market during the forecast period.
- The Cell Therapy Market is experiencing significant growth due
to the increasing demand for advanced treatments for cardiovascular
disorders. Microcarrier-based technologies are gaining popularity
in this market, particularly in emerging countries and
biopharmaceutical sectors. However, regulatory requirements pose
challenges for market expansion. Healthcare markets, drug research
activities, and vaccine production are key areas of application.
Plastic consumables are essential for cell culture, but their use
generates plastic waste, leading to environmental concerns.
Single-use bioprocessing is a cost-effective solution, reducing
process development time and capital investments. Solid waste
management is another challenge. Biopharmaceutical production,
diagnostics, tissue engineering, drug screening, monoclonal
antibodies, and vaccine production are major segments.
Biotechnology companies and diagnostic laboratories are major
players. Mergers and collaborations, such as between Captivate Bio
and Merck, are driving innovation in areas like viral vaccines,
biopharmaceutical development, pharmaceuticals, biotechnology,
testing kits, cell culture tools, organoids, high-throughput
screening, bioreactors, and artificial organs.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This cell culture market report extensively covers market
segmentation by
- Product
- 1.1 Consumables
- 1.2 Equipment
- End-user
- 2.1 Pharma and biotech companies
- 2.2 Hospitals
- 2.3 Research and academic Institutes
- 2.4 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Consumables- The cell culture market is driven
by the extensive use of consumables, which include sera, media, and
reagents. Sera consist of adult bovine sera (ABS), fetal bovine
sera (FBS), and other animal sera. Media encompasses serum-free
media, stem cell media, specialty media, and classical media and
salts. Reagents comprise supplements, growth factors, cell
dissociation reagents, contamination detection kits, antibiotics,
antimycotics, cell culture reagents, salt solutions, buffers, and
other accessories. The consumables segment dominates the market due
to their high availability, vast applicability, and repeated usage.
The affordability of consumables is another significant factor
driving their adoption. They are often sold along with compatible
instruments at a lower price than when bought separately. The
increasing diseased population necessitates the development of cell
culture-based products, such as Humulin, for treating conditions
like diabetes. The rising number of diabetic patients is expected
to boost the demand for Humulin and, consequently, for consumables.
Furthermore, the growing cell-based research and the increasing
demand for cell-based therapies have led vendors to invest in
R&D to develop advanced cell media, reagents, and supplements.
For instance, FUJIFILM Irvine Scientific Inc.'s BalanCD Gal
Supplement enhances galactosylation in biotherapeutic development,
contributing to improved product quality and antibody efficacy. The
availability of such innovative products will fuel the growth of
the consumables segment in the global cell culture market during
the forecast period.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data (2018 -
2022) - Download a Sample Report
Research Analysis
The Cell Culture Market is experiencing significant growth due
to the increasing demand for advanced cell-based research and
therapeutic applications. Buying behavior in this market is driven
by the need for single-use technologies that ensure sterility and
reduce contamination risks. Novel therapeutics, particularly those
targeting chronic diseases like cancer, cardiovascular ailments,
autoimmune disorders, and neurological disorders, are fueling
market expansion. The biotechnology industry plays a pivotal role
in cell culture research, with cell biology being a key area of
focus. Cell therapy is a promising application of cell culture,
with companies like CellVovant and the University of Bristel making
strides in this field. Seed funding and collaborations are
essential for the development of new cell culture technologies and
biopharmaceutical products. Viral vaccines, testing kits, cell
culture tools, organoids, high-throughput screening, bioreactors,
and Captivate Bio are some of the key areas of innovation in the
cell culture market.
Market Research Overview
The Cell Culture Market is a significant segment of the
biotechnology industry, driven by the increasing demand for novel
therapeutics, particularly in the areas of chronic diseases such as
cancer, cardiovascular ailments, autoimmune disorders, and
neurological disorders. Single-use technologies have gained
popularity due to their cost-effectiveness and ease of use,
reducing process development time and capital investments. The
market is also witnessing collaborations between academic
institutions, such as the University of Bristol, and biotechnology companies for seed
funding and research activities. The Biopharmaceutical sectors are
focusing on regulatory requirements and healthcare markets for drug
research, including vaccines, antibiotics, and therapeutic
proteins. The market includes plastic consumables, which have
raised concerns regarding plastic waste and the shift towards
single-use bioprocessing for cost reduction. The market also caters
to diagnostics, tissue engineering, drug screening, monoclonal
antibodies, and vaccine production. Companies like Merck and
Captivate Bio are leading players in this market, with innovations
in bioreactors, organoids, artificial organs, functional tissues,
and high-throughput screening.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- End-user
-
- Pharma And Biotech Companies
- Hospitals
- Research And Academic Institutes
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cell-culture-market-size-is-set-to-grow-by-usd-24-8-billion-from-2024-2028--increase-in-infectious-diseases-to-boost-the-market-growth-technavio-302209556.html
SOURCE Technavio